NCT 05501886 Brief Summary This is a Phase 3, open-label, randomized,…
Read more arrow_forwardNCT 02643511 Brief Summary Whole gland LDR brachytherapy has been a well…
Read more arrow_forwardNCT 01704716 Brief Summary This is a randomized study of the European…
Read more arrow_forwardNCT 05774873 Brief Summary The primary objective of this study to evaluate…
Read more arrow_forwardNCT 05987332 Brief Summary This is a Phase 2/3, multi-arm, multi-stage,…
Read more arrow_forwardNCT 05365659 Brief Summary This first-in-human study will evaluate the recommended dose…
Read more arrow_forwardNCT 06112314 Brief Summary This is a phase 3, randomized, controlled study…
Read more arrow_forwardNCT 04291885 Brief Summary The I-MAT trial is a randomised, placebo-controlled, phase…
Read more arrow_forwardNCT 03959085 Brief Summary This phase III trial studies whether inotuzumab ozogamicin…
Read more arrow_forwardNCT 04643002 Brief Summary The purpose of this umbrella study is to…
Read more arrow_forward